Richmond Pharmacology supports Cardior Pharmaceuticals with the pioneering trial of an oligonucleotide-based drug in heart failure patients
14
December 2020
Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics
20
October 2020
Richmond Pharmacology supports ReViral with the development of Sisunatovir
9
September 2020
Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran
17
August 2020